Muscle satellite cells from dystrophic (mdx) mice have elevated levels of heparan sulphate proteoglycan receptors for fibroblast growth factor

Journal of Muscle Research and Cell Motility

Volumn 19, Issue 1, 1998, Pages 43-51

  Crisona, Nancy J ^a   Allen, Karen D ^a,b   Strohman, Richard C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; IODINE 125; PROTEOHEPARAN SULFATE; RECEPTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CELL CULTURE; CONTROLLED STUDY; FIBROBLAST; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SATELLITE CELL; SKELETAL MUSCLE;

ANIMALS; CELLS, CULTURED; FIBROBLAST GROWTH FACTORS; FIBROBLASTS; HEPARAN SULFATE PROTEOGLYCANS; KINETICS; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, ANIMAL; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, FIBROBLAST GROWTH FACTOR; SENSITIVITY AND SPECIFICITY; STEM CELLS;

ANIMALIA;

EID: 0031974029     PISSN: 01424319     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005300426655     Document Type: Article

References (30)

1. AVIEZER, D., HECHT, D., SAFRAN, M., EISINGER, M., DAVID, G. & YAYON, A. (1994a) Perlican, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79, 1005-13.
2. AVIEZER, D., LEVY, E., SAFRAN, M., SVAHN, C., BUDDECKE, E., SCHMIDT, A., DAVID, G., VLODAVSKY, I. & YAYON, A. (1994b) Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem. 269, 114-21.
3. BULLFIELD, G., SILLER, W. G., WIGHT, P. A. L. & MOORE, K. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl Acad. Sci. USA 81, 1189-92.
4. CAMPBELL, K. P. (1995) Three muscular dystrophies: loss of cytoskeletal-extracellular matrix linkage. Cell 80, 675-9.
5. CLARKE, M. S., KHAKEE, R. & MCNEIL, P. L. (1993) Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. J. Cell Science 106, 121-33.
6. D'AMORE, P. A., BROWN, R. H. JR., HOFFMAN, E. P., WATANABE, H., ARAHATA, K., ISHIHARA, T. & FOLKMAN, J. (1994) Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Annals of Neurology 35, 362-5.
7. DIMARIO, J. & STROHMAN, R. C. (1988) Satellite cells from dystrophic (mdx) mouse muscle are stimulated by fibroblast growth factor in vitro. Differentiation 39, 42-9.
8. DIMARIO, J., BUFFINGER, N., YAMADA, S. & STROHMAN, R. C. (1989) Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) muscle. Science 244, 688-90.
9. FLORINI, J. R. & MAGRI, K. A. (1989) Effects of growth factors on myogenic differentiation. Am. J. Physiol. 256, C701-11.
10. GOSPODAROWICZ, D., CHENG, J., LIU, G., BAIRD, A. & BOHLENT, P. (1984) Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc. Natl Acad. Sci. USA 81, 6963-7.
11. HOFFMAN, E. P., BROWN, R. H., JR. & KUNKEL, L. M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-28.
12. INOUE, H., KATO, Y., IWAMOTO, M., HIRAKI, Y., SAKUDA, M. & SUZUKI, F. (1989) Stimulation of cartilage-matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor-beta. J. Cell. Physiol. 138, 329-37.
13. JOHNSON, D. E. & WILLIAMS, L. T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41.
14. KLAGSBRUN, M. & BAIRD, A. (1991) A dual receptor system is required for basic fibroblast growth factor activity. Cell 67, 229-31.
15. MATSUMURA, K. & CAMPBELL, K. P. (1994) Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle and Nerve 17, 2-15.
16. MAURO, A. (1961) Satellite cells of skeletal muscle fibers. J. Biophy. Biochem. Cytolo. 9, 493-5.
17. MOSCATELLI, D. (1987) High and low affinity binding sites for basic FGF on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol. 131, 123-30.
18. MOSCATELLI, D. (1988) Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J. Cell Biol. 107, 753-9.
19. MUNSON, P. J. & RODBARD, D. (1980) LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-39.
20. NEUFELD, G. & GOSPODAROWICZ, D. (1985) The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J. Biol. Chem. 260, 13860-8.
21. OLWIN, B. B. & HAUSCHKA, S. D. (1986) Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts. Biochemistry 25, 3487-92.
22. OLWIN, B. B. & RAPRAEGER, A. C. (1992) Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. J. Cell Biol. 118, 631-9.
23. PETROFF, B. J., SHRAGER, J. B., STEDMAN, H. H., KELLY, A. M. & SWEENEY, H. L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA 90, 3710-4.
24. RAPPOLEE, D. A., MARK, D., BANDA, M. J. & WERB, Z. (1988) Wound marcophages express TGF-beta and other growth factors in vivo: analysis by mRNA phenotyping. Science 241, 708-12.
25. RAPRAEGER, A. (1989) Transforming growth factor (type beta) promotes the addition of chondroirin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia. J. Cell Biol. 109, 2509-18.
26. RAPRAEGER, A. & YEAMAN, C. (1989) A quantitative solid-phase assay for identifying radiolabeled glycosaminoglycans in crude cell extracts. Anal. Biochem. 179, 361-5.
27. RAPRAEGER, A. C., KRUFKA, A. & OLWIN, B. B. (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705-8.
28. ROGHANI, M., MANSUKHANI, A., DELL'ERA, P., BELLOSTA, P., BASILICA, C., RIFKIN, D. B. & MOSCATELLI, D. (1994) Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269, 3976-84.
29. RUOSLAHTI, E. & YAMAGUCHI, Y. (1991) Proteoglycans as modulators of growth factor activity. Cell 64, 867-9.
30. YAYON, A., KLAGSBRUN, M., ESKO, J. D., LEDER, P. & ORNITZ, D. M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-8.